Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies.

H Brashear R, Ketter N, Bogert J, Di J, Salloway SP, Sperling R

J Alzheimers Dis. 2018; 66(4):1409-1424. PMID: 30412493. Abstract